Velasco, Febdrick A.
HRN: 21-46-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/14/2022
06/20/2022
IVT
110mg
OD
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes